Viromed Medical says cold plasma lung study results accepted by leading medical journal

Bitget2026/09/30 15:45

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Viromed Medical AG reported a study on cold atmospheric plasma use in the lung was accepted for publication in a leading medical journal.
Results have been presented to the journal through peer review; detailed findings will be presented publicly only after publication.
The study showed a meaningful reduction in infectious germs across pathogens in severe lung infections, including ventilator-associated pneumonia.
Researchers also identified a defined safety window, with analyses indicating no safety-relevant tissue damage within that range.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viromed Medical AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2408210_en) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Viromed Medical says cold plasma lung study results accepted by leading medical journal

You may also like

Crypto prices